Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone, Nicholas D; Thibodeaux, Quinn G; Reddy, Vidhatha D; Myers, Bridget A; Chan, Stephanie Y; Bhutani, Tina; Liao, Wilson

Brownstone, Nicholas D; Thibodeaux, Quinn G; Reddy, Vidhatha D; Myers, Bridget A; Chan, Stephanie Y; Bhutani, Tina; Liao, Wilson.

Afiliación

Brownstone ND; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Thibodeaux QG; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Reddy VD; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Myers BA; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Chan SY; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Bhutani T; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.
Liao W; Department of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA USA.

Dermatol Ther (Heidelb) ; 10(3): 339-349, 2020 Jun.

Article en En | MEDLINE | ID: mdl-32300516

Palabras clave

Biologics; COVID-19; Coronavirus; Infection; Pandemic; Psoriasis; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google